BrightSpring Health Services, Inc. Common Stock
NASDAQ Global SelectRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- BrightSpring Health Services, Inc. operates as a diversified provider of home and community-based health and pharmacy services primarily for medically complex and high-need populations across the United States. The company’s core offerings include behavioral health services such as applied behavior analysis and autism services; home health care encompassing personal care, home health, hospice, and neuro rehabilitation; pharmacy services including specialty, oncology, hospice, infusion, and community pharmacy; family and youth services; telecare and remote support solutions; and job placement and vocational training. These services are delivered under multiple brand names and supported by ancillary technologies aimed at improving patient outcomes. Founded in 1974 and headquartered in Louisville, Kentucky, BrightSpring employs over 37,000 full-time equivalents and serves more than 350,000 patients daily in all 50 states. Recently, BrightSpring Health Services has made significant strategic advancements including the acquisition of Haven Hospice to expand hospice services into Florida and Pate Rehabilitation to enhance rehabilitation offerings. The company also announced a $100 million equity grant to reward its workforce, reflecting its investment in employee engagement. Financially, BrightSpring reported strong growth with third-quarter 2025 revenues reaching $3.334 billion, a 28.2% year-over-year increase, driven by robust performance in both Pharmacy Solutions and Provider Services segments. The company raised its 2025 full-year revenue guidance to a projected $12.5 billion to $12.8 billion and adjusted EBITDA guidance to $605 million to $615 million, reflecting ongoing operational improvements and disciplined expense management. Additionally, BrightSpring plans to divest its Community Living segment, with the sale expected to close in early 2026 and was recently included in the S&P SmallCap 600 index as part of its market recognition. BrightSpring’s integrated platform serves Medicare, Medicaid, and commercially insured patients, emphasizing innovation through its Connected Home model of care and cutting-edge therapies such as Vitality Therapy. Its comprehensive service portfolio spans clinical, nonclinical, pharmacy, and ancillary care designed to address complex medical and behavioral health needs in community settings. The company’s recent expansions and strong financial performance underscore its leadership position in the home and community healthcare industry.
Company News
38,367 BrightSpring Health Services, Inc. $BTSG Shares Sold by State of Alaska Department of Revenue
BTSG Stock Climbs 67.3% YTD: What's Driving the Rally in 2026?
BrightSpring: Margins Keep Improving While Expanding Its Pharmacy Footprint
Top Healthcare Stocks: Playing Offense And Defense For The Win
BrightSpring Health Services, Inc. to Announce Third Quarter 2026 Financial Results on October 30, 2026
BTSG Deploys AI Across Operations: Will It Improve Margins?
BrightSpring Health Services, Inc. (BTSG) is a Top-Ranked Value Stock: Should You Buy?
BrightSpring vs. Option Care Health: Which Healthcare Stock Is Better?
BrightSpring Health Targets Growth Through Specialty Pharmacy, M&A and AI
BrightSpring Health Targets Growth Through Specialty Pharmacy, M&A and AI
Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve?
Best Momentum Stocks to Buy for September 24th
3 Momentum Anomaly Stocks to Buy as Markets Surge on AI Rally
BTSG Faces $200M IRA Hit but Efficiency May Protect Profitability
BrightSpring Health Services, Inc. (BTSG) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell?
BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?
BrightSpring Health Services: 44% Ebitda Growth Is Hard To Ignore
Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?